Cat# : THP-0309
Catalog# | Product Name | Availability | Size | Price | Qty |
---|---|---|---|---|---|
THP-0309 | Blisibimod, Recombinant Human BAFF/Tnfsf13b inhibitor | October 08, 2024 | 1 vial | $2,998.00 |
|
Add to Cart Online Order Request a Bulk Order |
Cat#: | THP-0309 |
Product Name: | Blisibimod, Recombinant Human BAFF/Tnfsf13b inhibitor |
Cas No: | 1236126-45-6 |
Description: | Blisibimod is a novel selective inhibitor of B-cell activating factor (BAFF), binds to both cell membrane-expressed and soluble BAFF. |
Sequences: | GCKWDLLIKQWVCDPLGSGSATGGSGSTASSGSGSATHMLPGCKWDLLIKQWVCDPLGGGGGVDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK |
Species: | Human |
Molecular Weight: | 63.58 kDa |
Purity: | >95% by SDS-Page and HPLC analysis |
Formula: | C2836H4376N756O858S26 |
Endotoxin: | <0.1 EU per 1 μg of the peptide by the LAL method |
Application: | Blisibimod has been used in trials studying the treatment of IgA Nephropathy, Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Granulomatosis With Polyangiitis. |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2024 Creative BioMart. All Rights Reserved.